Vasarya Therapeutics
Vasarya Therapeutics is developing targeted treatments for fibrotic disorders. Our novel therapeutic paradigm targets proteins that are only exposed in fibrotic tissue, allowing for inhibition of disease progression while avoiding toxicity associated with current, systemic standard of care therapies.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Vasarya Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- PH
Ping Hu
Director of Research · Research & Development
EmailPhone - JN
John Nicosia
Co-founder · Other
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Vasarya Therapeutics
2 distinct titles indexed · top 2 shown.
- 1co-founder
- 1director of research
Sign up to unlock all 3 contacts at Vasarya Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Vasarya Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.